Jerry Jia-Sobota, MBA
Principal-National Consulting Leader
Eric Jia-Sobota is the National Leader of EverGlade’s Consulting Services and a Founder of the Company. Eric’s consulting experience spans almost two decades across a breadth of industries, including, Federal Contracting, Life Sciences, Nonprofit, Technology, Construction, Healthcare, and others.
Eric is a renowned expert in government contracting and has regularly served as an expert on matters involving the Cost Accounting Standards. His experience includes cost allowability and allocability, indirect rate restructuring, contract termination claims, and commercial contracting issues.
Mr. Jia-Sobota also has extensive experience helping life sciences and nonprofit organizations obtain R&D funding. He has worked closely with HHS, and specifically BARDA to help facilitate a multitude of pandemic responses.
Andrew helps life sciences organizations identify federal opportunities for non-dilutive R&D funding, navigate the procurement process, win the awards, and successfully manage the programs. His clients include biotechnology, pharmaceutical, medical device and healthcare companies, as well as nonprofits, universities, and academic organizations.
Andrew has extensive experience with R&D programs funded by Consortium OTAs, the DOD, and HHS ― including BARDA, NIH, and CDC. He also brings supply chain experience having worked with the US Government on multiple industrial base expansion initiatives to establish domestic manufacturing capabilities for pharmaceuticals and personal protective equipment.
Andrew regularly designs and implements compliant cost accounting structures for companies receiving their first cost-reimbursable government award. This includes developing indirect rate structures and cost allocation methodologies in accordance with government cost accounting regulations, while also helping contractors to maximize profitability and minimize exposure to compliance risk.
In addition, Andrew has notable experience supporting contractors in a variety of claims and disputes including contract terminations for convenience or default, requests for equitable adjustment, bid protests, breach of contract claims, and False Claims Act suits. He has assisted with a variety of matters at the direction of counsel and under protective order.
Steve Morris, PhD
Steve has more than 25 years of experience in biotechnology and pharmaceutical development, including more than 13 years of experience working within the US Government as the Branch Chief, Antivirals and Antitoxins, CBRN Division, BARDA-ASPR, HHS.
Mr. Morris has a deep familiarity with the drug development lifecycle from discovery through preclinical and clinical development and licensure or approval.
He has extensive knowledge of USG non-dilutive funding mechanisms, contract negotiation, and post-award contract administration and deliverables.
He most recently led a consulting team at the world’s fifth-largest accounting and consulting firm helping clients secure hundreds of millions of dollars in funding through BARDA contracts and other Federal Awards.
Prior to consulting, he had a Senior leadership role at a vaccine development company.
Dan Paterson, CPA
Dan Paterson has spent his career navigating the federal contracting and procurement process, including supporting companies with R&D programs funded by both the DOD and HHS. As a consultant, he helped lead numerous government contract initiatives from contract development and negotiation to program management following award.
Dan is a Certified Public Accountant (CPA) and has helped manage compliance challenges associated with the Federal Acquisition Regulation (FAR), Cost Accounting Standards (CAS), OMB Circulars, and both Defense Contract Audit Agency (DCAA) and Defense Contract Management Agency (DCMA) Business System requirements. Dan has also designed and implemented multiple compliant cost accounting structures for companies and assisted contractors with the many challenges associated with navigating the government funding landscape and private/public partnership process.
Robert Seymour, PMP
Rob Seymour is a seasoned project manager and project analyst with more than two decades of experience within the Biotech and Biomedical industries. His broad experience includes vaccine and therapeutic development for various US Government and commercial clients, both domestic and international.
Prior to consulting, he served as a Sr. Project Manager and led numerous projects during his tenure. Most recently, he led a $90M Operation Warp Speed (Covid-19) Fill/Finish project from inception to completion. In addition to vaccine and therapeutic programs, Mr. Seymour has experience with device (autoinjector) development, was lead on several projects in support of domestic and international commercial clients and was project lead on a lab relocation within the Bay Area of California.
Prior to working within the Biotech Industry, Mr. Seymour worked in several finance and accounting positions for public and private organizations.
EverGlade Consulting is a certified LGBT-owned business. Diversity is at the heart of what we do every day. To us, diversity, equity, and inclusion are not just moral imperatives, they are integral to our mission—to help our clients develop holistic solutions that achieve lasting results and to build a firm that attracts, develops, excites, and retains exceptional people.